NSOIX
Price
$20.88
Change
+$0.11 (+0.53%)
Updated
Aug 21 closing price
Net Assets
155.1M
RBEGX
Price
$23.20
Change
+$0.11 (+0.48%)
Updated
Aug 21 closing price
Net Assets
23.51B
Interact to see
Advertisement

NSOIX vs RBEGX

NSOIX vs RBEGX Comparison Chart in %
View a ticker or compare two or three
VS
NSOIX vs. RBEGX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSOIX is a Hold and RBEGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RBEGX has more cash in the bank: 23.5B vs. NSOIX (155M). NSOIX (1.23) and RBEGX (1.18) have matching dividends . NSOIX was incepted earlier than RBEGX: NSOIX (15 years) vs RBEGX (12 years). NSOIX (1.38) is less costly to investors than RBEGX (1.14). NSOIX is a more actively managed with annual turnover of: 25.00 vs. RBEGX (2.00). RBEGX has a lower initial minimum investment than NSOIX: RBEGX (250) vs NSOIX (5000). NSOIX annual gain was more profitable for investors over the last year : 22.70 vs. RBEGX (11.93). RBEGX return over 5 years is better than : 28.63 vs. NSOIX (15.34).
NSOIXRBEGXNSOIX / RBEGX
Total Expense Ratio1.311.14115%
Annual Report Gross Expense Ratio1.381.14121%
Fund Existence15 years12 years-
Gain YTD15.2229.928153%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets155M23.5B1%
Annual Yield % from dividends1.231.18104%
Returns for 1 year22.7011.93190%
Returns for 3 years39.4649.1780%
Returns for 5 years15.3428.6354%
Returns for 10 years94.5379.41119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIEMX58.580.79
+1.37%
Driehaus Emerging Markets Growth Instl
ANTGX11.820.14
+1.20%
American Century Non-US Intrs Val G
RWIBX81.530.67
+0.83%
American Funds Cptl Wld Gr&Inc R-2
TGVYX58.300.26
+0.45%
Touchstone Dynamic Large Cap Growth Y
MUSBX40.970.18
+0.44%
MFS Blended Research Core Equity B